4suxxess welcomes you!



Setup. Growth. Restructuring. Turnaround.

 

At 4suxxess, we offer you a team of business architects dedicated to support your company with services designed to enable you to enhance your competitiveness - whether it’s overcoming barriers to success or developing markets locally and globally.

4suxxess provides experienced executive professionals, with the right skill sets to ensure success in challenging assignments and projects.


PharmaTimes: News RSS

UK Biobank attracts backing from GSK and Regeneron (Fri, 24 Mar 2017)
GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank.
>> Read More

NHS speeds up publication of hospital episode data (Fri, 24 Mar 2017)
The NHS has refined its processes for publishing Hospital Episode Statistics (HES), making the latest dataset available more than a month earlier.
>> Read More

First Humira biosimilar approved in Europe (Fri, 24 Mar 2017)
Amgen has won European approval for its first biosimilar, a version of AbbVie’s blockbuster Humira (adalimumab).
>> Read More

Shire’s rare blood disorder drug gets US fast track (Thu, 23 Mar 2017)
An experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration.
>> Read More

Three-quarters of CCGs failing to improve child mental health (Thu, 23 Mar 2017)
Almost three-quarters (73.2 percent) of local Clinical Commissioning Groups are failing to meet NHS England targets for improving children and young people’s mental health services (CAMHS), shows a new analysis by the Education Policy Institute.
>> Read More